AACR and St. Baldrick’s Foundation Announce Pediatric Cancer Research Grant Recipient
PHILADELPHIA – The American Association for Cancer Research (AACR) and the St. Baldrick’s Foundation today announced that Alanna Joyce...
Search/Filter
Loading...
More Than 10% of Samples From a Stool-based Colorectal Cancer Test May Be Unsatisfactory
Fewer than half of patients with unsatisfactory samples from fecal immunochemical tests completed follow-up testing within 15 months PHILADELPHIA...
AACR Applauds Confirmation of Dr. Monica Bertagnolli as NIH Director
PHILADELPHIA – Philip D. Greenberg, MD, FAACR, President of the American Association for Cancer Research (AACR), and Margaret Foti,...
Nearly Half of Oncology Drugs Approved Since 1998 Are Precision Therapies
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA – Of the 198 new...
Investigational Inhibitor of Active RAS Shows Clinical Promise
The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C...
New Investigational Targeted Therapy Shows Early Promise in Patients With Solid Tumors
Second-generation PRMT5 inhibitor targets synthetic lethality in several cancer types with MTAP loss BOSTON – AMG 193, a second-generation...
AACR Congratulates Fellows, Board Members, and Members Elected to the National Academy of Medicine
PHILADELPHIA – The American Association for Cancer Research (AACR) extends its warmest congratulations to the 15 AACR members who...
AACR Statement on Senator Dianne Feinstein’s Passing
Today, the American Association for Cancer Research (AACR) issued the following statement regarding the death of Senator Dianne Feinstein:...
Folakemi T. Odedina, PhD, Recognized with 2023 AACR Distinguished Lectureship on the Science of Cancer Health Disparities
ORLANDO, Fla. – The American Association for Cancer Research (AACR) will award Folakemi T. Odedina, PhD, with the 2023...
NCI-sponsored Cancer Clinical Trials Have Become More Diverse Over Past Two Decades
ORLANDO, Fla. – Compared to the year 2000, a greater proportion of NCI-sponsored early-phase clinical trial participants in 2022...